20 Best Low Volatility Stocks to Buy According to Analysts

4. Abbott Laboratories (NYSE:ABT)

Analyst Upside: 21.27%

Beta Value: 0.71

Number of Hedge Fund Holders: 70

Abbott Laboratories (NYSE:ABT) ranks among the best low volatility stocks to buy according to analysts. RBC Capital maintained its Outperform rating on Abbott Laboratories (NYSE:ABT) on July 15 and raised its price target from $145 to $147. The firm pointed to Abbott’s strong single-digit revenue and double-digit EPS growth potential as examples of its ability to provide top-tier financial growth in the medical technology industry.

According to RBC Capital’s intra-quarter checks, Abbott Laboratories (NYSE:ABT) maintains positive healthcare utilization in Q2. Moreover, Abbott’s diabetes brand, which has been attracting a lot of investor interest, was one of the several growth catalysts mentioned in the firm’s report. The less elective nature of Abbott’s medical device portfolio was also mentioned by RBC as a benefit.

RBC Capital’s sustained belief in Abbott Laboratories (NYSE:ABT) as the best-performing large cap in its coverage year-to-date is bolstered by other positives such as business momentum in diabetes care, favorable trends in diagnostics, stability in nutrition, and strength in established pharmaceuticals.

Abbott Laboratories (NYSE:ABT) is a leading global healthcare company that manufactures a wide range of branded generic medications, medical devices, diagnostics, and nutritional items.